Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
종목 코드 SRTS
회사 이름Sensus Healthcare Inc
상장일Jun 03, 2016
CEOMr. Joseph C. Sardano
직원 수35
유형Ordinary Share
회계 연도 종료Jun 03
주소851 Broken Sound Pkwy NW Ste 215
도시BOCA RATON
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호33487-3635
전화15619225808
웹사이트https://sensushealthcare.com/
종목 코드 SRTS
상장일Jun 03, 2016
CEOMr. Joseph C. Sardano
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음